Regulation, Safety, and Quality Assurance
Patients need to know that traditional medicines and practitioners are safe and reliable. Regulation, safety monitoring and quality assurance protect the public by setting standards for products, practice and training.
The Regulation, Safety, and Quality Assurance session at GSTIM 2027 brings together regulators, researchers, manufacturers and practitioners. It links closely with traditional medicine in global health and policy, where national and international rules are shaped.
Safe use of traditional medicine depends on good-quality products and well-trained practitioners. Contamination, adulteration and wrong dosing can cause harm. Clear rules help protect patients without blocking useful treatments. Regulators, manufacturers and practitioners all share this responsibility.
Key Topics in Regulation, Safety, and Quality Assurance
• Regulatory frameworks for traditional medicines
• Good manufacturing and agricultural practices
• Quality control and standardisation
• Contamination and adulteration testing
• Pharmacovigilance and adverse event reporting
• Herb–drug interaction safety
• Practitioner licensing and standards
• Product labelling and claims
• Pharmacopoeias and reference standards
• Harmonisation of regulations across countries
Recent Advances in Regulation, Safety, and Quality Assurance
Testing methods such as DNA barcoding, mass spectrometry and chemical fingerprinting are making it easier to detect adulterated or contaminated products. These methods support quality work on herbal medicine, phytotherapy, and medicinal plants and classical formulas from Ayurveda, Unani, Siddha, and traditional medical systems.
Pharmacovigilance systems are expanding to include traditional medicines, helping identify safety signals earlier. Clear standards also support safe integration of traditional medicine into modern healthcare.
Modern testing is improving detection of contaminants and fake products. More countries are setting up reporting systems for side effects. International standards are helping products meet the same requirements across borders. Practitioner licensing is becoming more common.
Who Should Attend the Regulation, Safety, and Quality Assurance Session
• Regulators and policy makers
• Quality assurance and quality control staff
• Pharmacovigilance and drug safety specialists
• Herbal and traditional medicine manufacturers
• Students and early-career researchers
• Practitioner associations and licensing bodies
Why Present Your Research in Regulation, Safety, and Quality Assurance
GSTIM 2027 brings regulators and industry together with researchers and practitioners. You can share findings and connect with colleagues in translational research and innovation in traditional medicine who need clear regulatory pathways. Regulators, industry and researchers attend this session. Sharing your work here helps raise safety standards worldwide.
Frequently Asked Questions
Can regulators present policy updates?
Yes. Regulatory updates and policy analyses are welcome.
Does this session include pharmacovigilance research?
Yes. Adverse event monitoring and safety research are key topics.
Where is GSTIM 2027 held?
GSTIM 2027 is held at Village Hotel Changi, Singapore, from 4 to 6 March 2027, with online participation.